VITARI will begin shipping in the second half of 2026, with pre-orders now open and early customer commitments already secured Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100. With the introduction of VITARI, Element now offers a comprehensive and cohesive portfolio of…
Healthier Capital, a leading health-tech venture capital firm, joins as a co-founder and sole external investor in seed round Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of genomics pioneer J. Craig Venter, Ph.D. DGI is developing the…
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale Illumina, Inc. (NASDAQ: ILMN) today introduced the world’s largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build…
Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale. As multiomic datasets grow rapidly in size and complexity, researchers…
AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research Foundation One Genomics, an AI-focused genomics company advancing de-aging research and co-founded by Harvard Professor George Church alongside former Harvard and MIT research fellows and alumni, today announced a strategic research collaboration agreement with the CiRA Foundation to advance precision genome…
Dr. Khan will advance Evidation’s management in real-world information by driving the medical technique for direct-to-participant multimodal information assortment to gasoline AI-powered discovery and proof technology. Evidation, the chief in direct-to-participant real-world information and well being analysis, at the moment introduced the appointment of Dr. Ghazanfar Khan as Chief Medical Officer. A doctor and international…
Proprietary agentic AI mannequin transforms genomic and real-world information into actionable insights throughout the complete drug lifecycle Enables sooner improvement of breakthrough therapies, together with tumor-agnostic most cancers remedies, by a 360-degree view of the precision medication panorama Empowers scientific researchers throughout the life sciences and healthcare continuum to carry out large-scale information evaluation for the development…
Dr. Murphy to steer the continued scale up and growth of Bexorg’s totally built-in AI and whole-human mind platform centered on CNS ailments Bexorg, Inc., the primary built-in AI and whole-human mind platform firm reworking central nervous system (CNS) drug discovery and improvement, at the moment introduced that Sean Murphy, Ph.D., has joined the corporate…
Accumulus Technologies is happy to welcome business veteran Mervyn Hall to its govt management group as Chief Commercial Officer. Prior to becoming a member of Accumulus, Hall served as the Senior Vice President of Commercial at Aetion, which was acquired by Datavant in July 2025. Before Aetion, Hall served as Chief Operating Officer and Board…
Complete Genomics, a number one innovator in genomic sequencing, right this moment introduced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a worldwide chief in AI-driven precision medication, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The firms purpose to broaden entry to precision oncology testing by providing the best-in-class…